We are live on ! Find out more

60 hedge funds and large institutions have $212M invested in Afya in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 29 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

9% more capital invested

Capital invested by funds: $195M → $212M (+$17.5M)

7.27% less ownership

Funds ownership: 38.85%31.59% (-7.3%)

17% less funds holding

Funds holding: 7260 (-12)

55% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 22

62% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 29

66% less call options, than puts

Call options by funds: $24K | Put options by funds: $70K

Holders
60
Holders Change
-12
Holders Change %
-16.67%
% of All Funds
0.94%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
10
Increased
11
Reduced
29
Closed
22
Calls
$24K
Puts
$70K
Net Calls
-$46K
Net Calls Change
+$164K
Name Holding Trade Value Shares
Change
Change in
Stake
BAMCO Inc
1
BAMCO Inc
New York
$50.9M -$3.1M -253,195 -7%
SoftBank Group
2
SoftBank Group
Japan
$34.2M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$23.6M +$5.33M +435,747 +35%
PL
4
Perpetual Ltd
Australia
$12.7M -$2.43M -198,574 -18%
Massachusetts Financial Services
5
Massachusetts Financial Services
Massachusetts
$12.4M +$1.99M +162,641 +23%
CS
6
Credit Suisse
Switzerland
$9.17M -$385K -31,468 -5%
Morgan Stanley
7
Morgan Stanley
New York
$5.89M -$510K -41,699 -9%
Millennium Management
8
Millennium Management
New York
$5.86M -$3.74M -305,251 -42%
APA
9
Arisaig Partners (Asia)
Singapore
$5.52M -$657K -53,700 -12%
Amundi
10
Amundi
France
$5.06M -$100K -8,191 -2%
DekaBank Deutsche Girozentrale
11
DekaBank Deutsche Girozentrale
Germany
$4.77M -$3.97M -324,450 -48%
SC
12
Sagil Capital
United Kingdom
$4.71M +$4.11M +335,436 New
Marshall Wace
13
Marshall Wace
United Kingdom
$4.44M -$2.78M -227,076 -42%
Fidelity International
14
Fidelity International
Bermuda
$4.34M -$263K -21,476 -6%
SGDR
15
SPX Gestao de Recursos
Brazil
$4.32M +$3.76M +307,433 New
State Street
16
State Street
Massachusetts
$2.08M +$517K +42,263 +40%
RG
17
Renaissance Group
Kentucky
$1.92M +$336K +27,475 +25%
Renaissance Technologies
18
Renaissance Technologies
New York
$1.9M +$239K +19,500 +17%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$1.8M -$964K -78,733 -38%
Wellington Management Group
20
Wellington Management Group
Massachusetts
$1.76M -$364K -29,707 -19%
Bank of America
21
Bank of America
North Carolina
$1.41M +$286K +23,375 +30%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
22
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.21M
Invesco
23
Invesco
Georgia
$951K -$1.91K -156 -0.2%
Envestnet Asset Management
24
Envestnet Asset Management
Illinois
$825K -$368K -30,032 -34%
Citadel Advisors
25
Citadel Advisors
Florida
$797K -$2.33M -190,687 -77%

AFYA Hedge Fund Activity: Q2 2023 in Review

60 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Afya (AFYA) for Q2 2023, worth a combined $212M — up 9% from $195M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of AFYA and 10 opened new positions — a net loss of 12 holders — while 29 trimmed existing stakes and 11 added.

The largest buyer was Fidelity Investments, adding an estimated $5.33M. The largest seller was Ameriprise, exiting entirely with an estimated $10.5M sold.

  • 60 institutional investors held Afya (AFYA) as of Q2 2023, down from 72 in Q1 2023.
  • Funds reported $212M of Afya stock for Q2 2023, up 9% quarter-over-quarter.
  • 10 funds opened new Afya positions in Q2 2023 and 22 closed out, a net change of -12 holders.
  • The largest Afya buyer in Q2 2023 was Fidelity Investments, an estimated $5.33M added.
  • The largest Afya seller in Q2 2023 was Ameriprise, an estimated $10.5M sold.

Based on aggregated 13F filings for Q2 2023.